Nov 10, 2023
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $24000.00 to $20000.00.
The split itself did not change the total investment value.
Vaxcell-Bio Therapeutics (KRX:323990) operates in the Biotechnology industry.
Vaxcell-Bio Therapeutics company overviewVaxcell-Bio Therapeutics's most recent stock split was on November 10, 2023. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Vaxcell-Bio Therapeutics (KRX:323990) has split its stock 3 times: a 2-for-1 split on December 30, 2020, a 167-for-151 split on September 20, 2023, and a 6-for-5 split on November 10, 2023.
Vaxcell-Bio Therapeutics has split its stock 3 times. This history records 3 forward splits between December 30, 2020 and November 10, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Vaxcell-Bio Therapeutics's 6-for-5 split on November 10, 2023, every 5 shares became 6 shares.
Vaxcell-Bio Therapeutics has not announced a new split in our records. Its most recent split was on November 10, 2023, 3 years ago. Companies announce splits in advance, and any new KRX:323990 split will appear on this page.
Already premium?